tiprankstipranks
Candel Therapeutics (CADL)
NASDAQ:CADL
US Market

Compare Candel Therapeutics (CADL) vs. Competitors

440 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Candel Therapeutics
$4.83
$353.78M
-7.84
1.26%
4 Buy
1 Hold
0 Sell
Strong Buy
Tonix Pharma
$15.08
$167.30M
-1.07
-27.86%
2 Buy
0 Hold
0 Sell
Moderate Buy
Quantum-Si
$0.74
$160.22M
-2.15
-36.75%
2 Buy
1 Hold
0 Sell
Moderate Buy
Humacyte
$0.64
$143.29M
-3.72
-58.92%
5 Buy
1 Hold
0 Sell
Strong Buy
Monte Rosa Therapeutics
$17.48
$1.40B
-33.72
321.20%
7 Buy
0 Hold
0 Sell
Strong Buy
Inhibrx Biosciences Inc
$85.32
$1.10B
564.93%
1 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
CADL
Candel Therapeutics
4.83
-0.34
-6.58%
TNXP
Tonix Pharma
12.48
-3.67
-22.72%
QSI
Quantum-Si
0.74
-0.49
-39.84%
HUMA
Humacyte
0.65
-0.85
-56.71%
GLUE
Monte Rosa Therapeutics
17.48
13.07
296.37%
INBX
Inhibrx Biosciences Inc
75.27
63.39
533.59%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts